- Anyone interested in biodegradable microneedle applications
- Anyone working on nanoparticle pharmaceutical forms
- Researchers, professors
- Students
- How to use the Zetasizer to characterize nanoparticle materials
- Why nanoparticle characterization is key to optimizing performance in real-world applications
- How to prepare and run experiments to optimize transdermal drug delivery via microneedle array
Ask an Expert!
Development and characterization of starch/gelatin microneedle arrays loaded with lecithin/gelatin nanoparticles of losartan for transdermal delivery
May 25, 2023 | 16:30 - 17:30 CET | Virtual
About The Event
The aim of this work was to develop and characterize biodegradable polymeric microneedle arrays loaded with (i) losartan potassium powder and (ii) nanoparticles loaded with losartan potassium dispersed in a polymeric matrix (starch/gelatin), as innovative pharmaceutical forms intended to be used for blood pressure control. The lecithin/gelatin nanoparticles were prepared by the desolvation method. The independent variables were the lecithin/gelatin amount and the stirring speed, while particle size, PDI (polydispersity index), and entrapment efficiency were the dependent variables studied. The optimized nanoparticle formulation was also characterized in terms of ζ potential and morphology. The mold of the microneedle manufacture was created using a 3D printer by molding, and the microneedle arrays were prepared using the micromolding method. The independent variables were the starch/gelatin amount and drug form, while the fracture force, bioadhesion, and post-wetting bioadhesion were the dependent variables evaluated. The optimized microneedle array formulations were also characterized and evaluated in terms of morphology, release profiles, and in-vitro losartan skin permeation studies. The optimized nanoparticle formulation was of 170.3 ± 3.1 nm in size, with 0.201 ± 0.013 of PDI, 40.45 ± 2.27% of entrapment efficiency, and − 32.9 ± 0.8 mV of ζ potential. The mold had an array of 25 microneedles with a height of 1.5 mm each. The optimized microneedle arrays were successful in terms of fracture force, with a value of 408.3 ± 6.1 gf for MP and 320.2 ± 17.4 gf for MN. The results of in-vitro skin permeation studies indicated that therapeutic losartan concentrations can be reached by using a microneedle array of 49 cm2 for MP and 13 cm2 for MN. The optimal formulation of the microneedle array with nanoparticles constitutes the most suitable option for skin losartan delivery. For inclusion in the webinar presentation, questions and data can be submitted up to 10 days in advance by emailing askanexpert@malvernpanalytical.com. There is also the opportunity to ask questions on the day.
More information
Who should attend?
What will you learn?
Our popular ‘Ask an Expert’ webinar series is meant for students, researchers, and professors who want to deepen their knowledge, sharpen their analytical methods, or find out how to improve their data.
The free webinars provide extensive materials analysis information and answer your most frequently asked questions. They’re the ideal way to improve your materials science research and engineering knowledge.
We’ll assume you’ve watched our previous webinars if we’ve explored a topic before. Don't worry if you missed it or can't remember it – you can watch previous webinars here.
For a full overview of the 2023 program, click here.
To watch our webinars from previous years, take a look at the full program recordings here.